Visceral leishmaniasis: a challenging diagnosis in internal medicine


如何引用文章

全文:

详细

Leishmaniasis is a vector-born parasitic disease characterized by predominant cutaneous or visceral involvement with fever, hepatosplenomegaly and anemia. Leishmaniasis has relatively high prevalence in tropical and subtropical areas. Several sporadic and mostly imported cases are detected in Russian Federation. Nevertheless, some local incidents are noted in southern areas (Crimea, Dagestan). Lack of epidemiological alertness hampers confirmation of diagnosis and may lead to incorrect treatment. The article summarizes current state of knowledge in epidemiology, diagnostic approach and treatment of leishmaniasis. Particular clinical case is discussed.

 

作者简介

M. Brovko

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru
ORCID iD: 0000-0003-0023-2701

к.м.н., зав. отд-нием профпатологии и пульмонологии, Клиника им. Е.М. Тареева, Университетская клиническая больница №3

俄罗斯联邦, Moscow

L. Akulkina

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru
ORCID iD: 0000-0002-4307-8882

врач отд-ния профпатологии и пульмонологии, Клиника им. Е.М. Тареева, Университетская клиническая больница №3

俄罗斯联邦, Moscow

P. Potapov

Lomonosov Moscow State University

Email: vsholomova@mail.ru
ORCID iD: 0000-0003-4366-2832

клинический ординатор каф. внутренних болезней фак-та фундаментальной медицины

俄罗斯联邦, Moscow

V. Sholomova

Sechenov First Moscow State Medical University (Sechenov University)

编辑信件的主要联系方式.
Email: vsholomova@mail.ru
ORCID iD: 0000-0002-8785-7968

врач-пульмонолог отд-ния профпатологии и пульмонологии Клиники им. Е.М. Тареева, Университетская клиническая больница №3, ассистент каф. внутренних, профессиональных болезней и ревматологии

俄罗斯联邦, Moscow

M. Lebedeva

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru

к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии

俄罗斯联邦, Moscow

T. Nekrasova

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru
ORCID iD: 0000-0001-6376-9392

к.м.н., доц. каф. патологической анатомии им. А.И. Струкова

俄罗斯联邦, Moscow

V. Varshavskii

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru

д.м.н., проф. каф. патологической анатомии им. А.И. Струкова

俄罗斯联邦, Moscow

E. Volchkova

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru

д.м.н., проф., зав. каф. инфекционных болезней

俄罗斯联邦, Moscow

T. Rozina

Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University

Email: vsholomova@mail.ru
ORCID iD: 0000-0002-7939-1416

к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии; доц. каф. внутренних болезней фак-та фундаментальной медицины 

俄罗斯联邦, Moscow

E. Nikulkina

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru
ORCID iD: 0000-0001-6084-8749

ассистент каф. внутренних, профессиональных болезней и ревматологии

俄罗斯联邦, Moscow

L. Karan

Central Research Institute of Epidemiology

Email: vsholomova@mail.ru
ORCID iD: 0000-0002-5927-460X

науч. сотр.

俄罗斯联邦, Moscow

S. Moiseev

Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University

Email: vsholomova@mail.ru
ORCID iD: 0000-0002-7232-4640

д.м.н., проф., дир. Клиники им. Е.М. Тареева, зав. каф. внутренних, профессиональных болезней и ревматологии

俄罗斯联邦, Moscow

V. Fomin

Sechenov First Moscow State Medical University (Sechenov University)

Email: vsholomova@mail.ru
ORCID iD: 0000-0002-2682-4417

чл.-кор. РАН, д.м.н., проф., зав. каф. факультетской терапии №1

俄罗斯联邦, Moscow

参考

  1. World Health Organization, Working to overcome the global impact of neglected tropical diseases: First WHO Report on neglected tropical diseases (Geneva: World Health Organization 2010). Accessed 7 Oct 2018.
  2. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, et al. Leishmaniasis: a review. F1000 Res. 2017;6:750.
  3. WHO. Epidemiological situation. WHO – 2018.
  4. Баранец М.С., Ермак Т.Н., Понировский Е.Н. Клинико-эпидемиологические особенности висцерального лейшманиоза в Республике Крым. Терапевтический архив. 2017;89(11):100-4 [Baranets MS, Ermak TN, Ponirovsky EN. Clinical and epidemiological features of visceral leishmaniasis in the Republic of Crimea. Therapeutic Archive. 2017;89(11):100-4 (In Russ.)]. doi: 10.17116/terarkh20178911100-104
  5. Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017;96(1):24-5. doi: 10.4269/ajtmh.16-84256
  6. Srivastava P, Dayama A, Mehrotra S, et al. Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2011;105(1):1-6. doi: 10.1016/j.trstmh.2010.09.006
  7. Antinori S, Calattini S, Longhi E, et al. Clinical Use of Polymerase Chain Reaction Performed on Peripheral Blood and Bone Marrow Samples for the Diagnosis and Monitoring of Visceral Leishmaniasis in HIV-Infected and HIV-Uninfected Patients: A Single-Center, 8-Year Experience in Italy and Review of the Literature. Clin Infect Dis. 2007;44(12):1602-10. doi: 10.1086/518167
  8. Boelaert M, Verdonck K, Menten J. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev. 2014. doi: 10.1002/14651858.CD009135.pub2
  9. Hickey AJ, Gounder L, Moosa M-YS, et al. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis. 2015;15:209. doi: 10.1186/s12879-015-0944-6
  10. Dean AS, Crump L, Greter H, et al. Clinical Manifestations of Human Brucellosis: A Systematic Review and Meta-Analysis. PLoS Negl Trop Dis. 2012;6(12):e1929с. doi: 10.1371/journal.pntd.0001929
  11. Shaker Y, Samy N, Ashour E. Hepatobiliary Schistosomiasis. J Clin Transl Hepatol. 2014;2(3):212-6. doi: 10.14218/JCTH.2014.00018
  12. Kawakami A, Fukunaga T, Usui M. Visceral leishmaniasis misdiagnosed as malignant lymphoma. Intern Med. 1996;35(6):502-6. doi: 10.2169/internalmedicine.35.502
  13. Yabe M, Miranda RN, Medeiros LJ. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. Hum Pathol. 2018;74(5):16. doi: 10.1016/j.humpath.2018.01.005
  14. Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095-102. doi: 10.1182/blood-2016-09-692541
  15. Lamy T, Moignet A, Loughran TP. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082-94. doi: 10.1182/blood-2016-08-692590
  16. Owlia MB, Newman K, Akhtari M. Felty’s Syndrome, Insights and Updates. Open Rheumatol J. 2014;8(129):36. doi: 10.2174/1874312901408010129
  17. Liberopoulos E, Kei A, Apostolou F, et al. Autoimmune manifestations in patients with visceral leishmaniasis. J Microbiol Immunol Infect. 2013;46(4):302-5. doi: 10.1016/j.jmii.2012.01.016
  18. Santana IU, Dias B, Nunes EAS. Visceral leishmaniasis mimicking systemic lupus erythematosus: Case series and a systematic literature review. Semin. Arthritis Rheum. 2015;44(6):658-65. doi: 10.1016/j.semarthrit.2014.12.004

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2020

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##